Guttman-McCabe Christopher 4
4 · Anterix Inc. · Filed Jan 21, 2025
Insider Transaction Report
Form 4
Anterix Inc.ATEX
Guttman-McCabe Christopher
Chief Reg & Comm Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-16+67,774→ 67,774 totalExercise: $27.83Exp: 2035-01-16→ Common Stock (67,774 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in three equal annual installments with vesting commencing on January 16, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.